FDA Inspection 1305576 — Magesh Rajagopal, MBBS
The FDA completed an inspection of Magesh Rajagopal, MBBS on Feb 7, 2026 in Tiruchirappalli. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Feb 7, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Tiruchirappalli (India)
Additional details
Clinical BA/BE